Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia
(Q28257174)
scientific article
scientific article
Language:
(P31) |
(Q13442814)
|
||||||||||||||||||||||||||||||||||
(P304) |
4110-6
|
||||||||||||||||||||||||||||||||||
(P407) |
(Q1860)
|
||||||||||||||||||||||||||||||||||
(P433) |
18
|
||||||||||||||||||||||||||||||||||
(P478) |
23
|
||||||||||||||||||||||||||||||||||
(P577) |
Monday, June 20, 2005
|
||||||||||||||||||||||||||||||||||
(P921) |
(Q974135)
(Q6934595) (Q79460)
(Q29496)
(Q264118)
(Q422248)
|
||||||||||||||||||||||||||||||||||
(P1433) |
(Q400292)
|
||||||||||||||||||||||||||||||||||
(P1476) |
"Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia" (language: en)
|
||||||||||||||||||||||||||||||||||
(P2093) |
Eric J Feldman
Joseph Brandwein
Richard Stone
Matt Kalaycio
Joseph Moore
Julie O'Connor
Nancy Wedel
Gail J Roboz
Carole Miller
Raj Chopra
Joseph C Jurcic
Randy Brown
W Christopher Ehmann
Philip Schulman
Stanley R Frankel
Daniel De Angelo
David Scheinberg
|